CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Breast Cancer

RESEARCH REPORT 

Lower Risk of ER-Negative Breast Cancer Linked to Vegetable Consumption

By Anna Azvolinsky, PhD1 | February 6, 2013
1Freelance Science Writer and Cancer Network Contributor. Follow Her on Twitter

Consuming more vegetables is associated with a lower risk of estrogen receptor (ER)-negative breast cancer, according to a new study published in the Journal of the National Cancer Institute. Researchers from Harvard Medical School did not observe a link between the total fruit and vegetable intake and overall risk of breast cancer or risk of ER-positive breast cancer.

Seungyoun Jung, ScD, of the Brigham and Women’s Hospital and Harvard Medical School, and colleagues analyzed more than 990,000 women in 20 cohort studies who were followed for 11 to 20 years. The researchers compared breast cancer outcomes among the groups who had the lowest and highest fruit and vegetable consumption.

The combined relative risk of the highest vs the lowest quartile of total vegetable intake was 0.82 for ER-negative breast cancer and 1.04 for ER-positive breast cancer (P < .001). Total fruit consumption was not statistically significantly associated with ER-negative breast cancer risk (0.94 relative risk). Analysis of specific fruits and vegetables showed a statistically significant inverse association for consumption of apples, pears, peaches, nectarines, apricots, strawberries, carrots, and lettuce with risk of ER-negative breast cancer.

Unlike ER-positive breast cancer, few risk factors have been identified for ER-negative breast cancer. Evidence that higher fruit and vegetable intake can lower overall breast cancer risk is inconclusive, but several smaller studies had shown that ER-negative breast cancer risk is lower with higher consumption. Because ER-negative breast cancer accounts for only 15% to 20% of all breast cancers, it is difficult to get a large enough cohort to assess significance. The current study is a large pooled cohort of women that were followed long-term and included many ER-negative breast cancer cases.

The biological mechanism of how components of fruits and vegetables may help to prevent ER-negative breast cancer is not clear. The authors suggest that the active compounds in vegetables and fruit may reduce the expression of epidermal growth factor receptor (EGFR), which is overexpressed in ER-negative breast cancers. Phytochemicals in vegetables have been suggested to lower the level of EGFR. The relevant parts of vegetables may be more concentrated in vegetables compared to fruit and more effective in preventing ER-negative cancer. The authors note that alpha-carotene, beta-carotene, and lutein/zeaxanthin (all of which are particularly abundant in vegetables) have each been inversely linked to the risk of ER-negative breast cancer in previous studies that used the same pooled cohorts as this study. A link was found for beta-cryptoxanthin, a component that is highly abundant in fruits, but it was not statistically significant.

“These findings support the value of examining etiologic factors in relation to breast cancer characterized by hormone receptor status in large pooled analyses because modest associations with less common breast cancer subtypes may have been missed in smaller studies,” state the authors.

Limitations of the study include the variability in reporting food intake and only a single measurement of fruit and vegetable consumption as a baseline reference. Additionally, 10 to 20 years may not be enough time to accurately assess consumption as breast cancer generally has a long duration time for development.

In an accompanying editorial, Cynthia A. Thomson and Patricia A. Thompson, of the College of Public Health at the University of Arizona, highlight that the authors of the study provide evidence, consistent across the 20 pooled studies, for the protective effect of fruit and vegetable consumption for ER-negative breast cancer. Thomson and Thompson also point out that ER-negative disease, and especially triple-negative breast cancer, is disproportionately associated with younger women, Hispanic and black women, and women in areas of low socioeconomic status. The increased risk among these women is thought to reflect different life choices and circumstances—higher parity, socioeconomic status, and not race or ethnicity.

The take-home message? “The findings support the emphasis of public messages for greater vegetable and selective fruit intake by extending a potential benefit for ER-negative breast cancer,” state the editorial authors. The challenge now is to reaffirm these findings in a larger and more diverse population.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
RELATED CONTENT

50 Shades of Pink—And Why It Helps to Know the Difference
May 17, 2013
It’s Time for Clinicians to Reconsider Their Proscription Against the Use of Soyfoods by Breast Cancer Patients
ONCOLOGY,  May 13, 2013
HERA Trial: Invasive Lobular Breast Carcinoma Patients Derived Same Benefit From Trastuzumab Maintenance
May 7, 2013
PIK3CA Mutations Negatively Affect Survival in Trastuzumab-Treated HER2-Positive Breast Cancer
May 6, 2013
US Task Force Recommends Breast Cancer Medications for High-Risk Women
April 24, 2013
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Skin Lesions
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
Click here to subscribe to our newsletter



CancerNetwork on Facebook
 
SearchMedica SEARCH RESULTS

Find peer-reviewed literature and websites for practicing medical professionals

CME on Breast Cancer
Evidence on Breast Cancer
Guidelines on Breast Cancer
Patient Education on Breast Cancer
Clinical Trials on Breast Cancer
Practical Articles on Breast Cancer
Research and Reviews on Breast Cancer
All "Breast Cancer" results

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy